Barclays’s SQZ Biotechnologies Company SQZ Stock Holding History

Barclays’s Portfolio SQZ Stock Details SQZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,794	Closed	-$144	–	5459
2023 Q3	$144	Hold	1,794	–	–	﹤0.01%	4538
2023 Q2	$484	Hold	1,794	–	–	﹤0.01%	4390
2023 Q1	$1K	Hold	1,794	–	–	﹤0.01%	4930
2022 Q4	$1.33K	Hold	1,794	–	–	﹤0.01%	5105
2022 Q3	$4K	Hold	1,794	–	–	﹤0.01%	4560
2022 Q2	$6K	Sell	1,794 -3,698	-67%	-$13.3K	﹤0.01%	4764
2022 Q1	$27K	Buy	+5,492	New	+$34.9K	﹤0.01%	4344

Barclays's SQZ Position: Q4 2023 in Review

Barclays sold out of SQZ Biotechnologies Company (SQZ) in Q4 2023, closing a stake of 1,794 shares — an estimated $144 sold.

Barclays first reported a position in SQZ in Q1 2022 and held it in 7 quarters. The position peaked at $27K in Q1 2022. 0 funds tracked by Wall St. Rank hold SQZ as of Q4 2023.

Barclays reported no remaining SQZ Biotechnologies Company position as of Q4 2023 after selling out during the quarter.
Barclays sold 1,794 SQZ Biotechnologies Company shares in Q4 2023, an estimated $144.
Barclays first reported a position in SQZ Biotechnologies Company in Q1 2022 and held it in 7 quarters.
Barclays's SQZ Biotechnologies Company position peaked at $27K in Q1 2022.
0 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q4 2023.

Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.